Read + Share
Frias JP. What is the 'real-world' experience with fixed-ratio combination therapy (insulin
+ GLP-1 receptor agonist) in routine clinical practice? Take-home messages for
clinicians regarding key outcomes. Diabetes Obes Metab 2025;27 Suppl 7.
PMID: 40637050
|
 |
|
